RPS24P18

Across TCGA pan-cancer cohorts, RPS24P18 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of RPS24P18’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where RPS24P18 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPS24P18 is over-expressed in tumor, although a few such as PAAD and BRCA show the opposite, repressed pattern.

KIRC, PAAD, and PRAD are the cancer types where RPS24P18 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPS24P18 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	All	+0.032	.024	3	view →
PAAD	Female	All	−0.245	.046	2	view →
PRAD	All	All	+0.091	.001	2	view →
HNSC	Male	II,III,IV	+0.057	.037	2	view →
BRCA	Female	All	−0.046	.028	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

RPS24P18–KIRC

Open the KIRC breakdown →